Experience real-time quotes &

news with the most powerful

iPhone application for investors.

Get the FREE DailyFinance iPhone application



  • VANDA PHARMACEUTICALS INC Analyst Recommendations

  • Analyst Consensus: VNDA

    First Call Consensus Recommendation

    • Strong Buy1
    • Buy2
    • Hold3
    • Sell4
    • Strong Sell5
    Mean Analyst Consensus Recommendation Analysts Reporting
    Current Recommendation 1.000 Strong Buy 2
    30 Days Ago 1.000 Strong Buy 2
    60 Days Ago 2.333 Buy 3
    90 Days Ago 2.333 Buy 3
    120 Days Ago 3.000 Hold 2
  • Analyst Ratings: VNDA

    Brokerage Firm Previous Rating Current Rating Change Date Price Target
    Banc of America Sec Buy Neutral 07/29/2008
    JP Morgan Overweight Neutral 07/29/2008
    Caris & Company Buy Above Average 07/28/2008 3.00
    Friedman Billings Outperform 07/10/2008
    Caris & Company Buy 05/02/2008 22.00
    Friedman Billings Outperform 11/09/2007 16.00
    Friedman Billings Outperform 11/01/2007 31.00
    Banc of America Sec Buy 09/10/2007
    Citigroup Hold 05/08/2007
    Friedman Billings Outperform 05/01/2007 37.00
    Friedman Billings Outperform 02/14/2007 40.00
    Thomas Weisel Outperform 05/23/2006 15.00
    Banc of America Sec Buy 05/23/2006 14.00
    JP Morgan Overweight 05/22/2006